Helen of Troy, the consumer products company behind brands like OXO and Vicks, raised its fiscal 2027 sales outlook after a stronger-than-expected first quarter. But the company left its adjusted earnings guidance unchanged, leaving investors to debate whether the full-year profit view is too cautious or a sign of underlying margin pressure.
The stock jumped more than 11% in Thursday trading, signaling that the market welcomed the revenue beat even as questions linger about profitability.
What happened
Helen of Troy nudged its fiscal 2027 net sales forecast to a range of $1.76 billion to $1.83 billion, up from the prior range of $1.75 billion to $1.82 billion. The company held its adjusted earnings per share (EPS) guidance steady at $3.25 to $3.75.
UBS, an investment bank, noted that the first quarter beat expectations on both sales and operating margins. But the unchanged profit guide is the bigger signal for analysts. When a company raises revenue expectations without raising EPS, it often implies it is assuming lower profit per dollar of sales. That could be because costs are rising, the product mix is shifting toward less profitable items, or management is building in a buffer against uncertainty. It can also mean profits are expected to come later in the fiscal year, even if early-quarter momentum looks strong.
Why the profit guidance matters
For investors, the key question is whether the stronger sales will eventually flow through to earnings. If higher revenue translates into higher profits, the stock could be undervalued at current levels. If not, the sales raise looks less impressive because it suggests more spending or weaker profitability is needed to generate that growth.
UBS currently forecasts fiscal 2027 sales of $1.79 billion and adjusted EPS of $3.55. The bank has a neutral rating on the stock and a price target of $25. That target highlights how quickly the stock’s jump to $27.97 can get ahead of a still-cautious full-year profit story.
At $27.97, Helen of Troy is trading at roughly 8 times the midpoint of management’s EPS range of about $3.50. UBS’s $25 target, based on $3.55 EPS, implies a multiple closer to 7 times. That gap shows why investors are split: the stock’s valuation depends on whether upcoming results look more like management’s cautious assumptions or more like the stronger first-quarter run rate.
What it means for investors
This setup turns a solid quarter into a margin debate. If higher sales drop through to earnings, the market can justify paying more for the same EPS stream because estimates could move up. If they don’t, the sales raise is less meaningful.
For everyday investors, the takeaway is that a company raising its sales outlook is generally positive, but it is only half the story. The real test is whether the company can convert that revenue growth into profit growth. In the coming weeks, analysts will likely focus on margin assumptions and cost trends rather than just the top-line number.
Helen of Troy’s situation is not unique. Other consumer goods companies have faced similar dynamics as input costs and shifting consumer preferences squeeze margins. For example, PepsiCo recently reported strong international sales but faced margin pressures in North America, and Simply Good Foods lifted its outlook after a profit beat despite a slump in its Atkins brand.
Looking ahead
Investors will watch for updates on cost trends, product mix, and any signs that the stronger first-quarter momentum is continuing. The next few weeks may be less about the sales number and more about analysts revising margin assumptions.
If Helen of Troy can show that the higher sales are translating into better profitability, the stock could have room to run. If margins remain under pressure, the current valuation may be harder to justify.
For now, the market has given the company the benefit of the doubt. But the debate over the profit outlook is far from settled.
